Reticulocyte Count, Edta Whole Blood

Reticulocyte count measures the number of reticulocytes (immature red blood cells) in a blood sample. These cells are produced in the bone marrow and released into the bloodstream when the body is responding to anemia or other blood disorders. The test uses an EDTA anticoagulant to prevent the blood from clotting and to preserve cell integrity.

Reticulocytes are an early form of red blood cells and their presence in the bloodstream indicates how well the bone marrow is functioning to produce new blood cells. Reticulocytes typically make up a small percentage of the total red blood cells but can increase significantly during periods of blood loss or anemia.

• Assessment of bone marrow function: The reticulocyte count provides insight into how well the bone marrow is responding to the body's need for red blood cells, especially in cases of anemia or blood loss.
• Diagnosis of anemia: In cases of anemia, this test helps determine if the bone marrow is adequately compensating by producing new red blood cells. For example, in hemolytic anemia (where red blood cells are destroyed prematurely), the reticulocyte count will be elevated as the body works to replace lost cells.
• Monitoring recovery from blood loss: After significant blood loss (e.g., from surgery or trauma), the bone marrow increases the production of reticulocytes to replenish the lost blood volume.
• Evaluating response to treatments: For patients undergoing treatments like chemotherapy or bone marrow stimulants (e.g., erythropoietin), the reticulocyte count can help monitor the effectiveness of these therapies.

• Patients with anemia or symptoms related to low red blood cell counts, such as fatigue, weakness, or pallor.
• Individuals with hemolytic anemia (when red blood cells are destroyed prematurely), such as in autoimmune conditions, certain infections, or hereditary blood disorders like sickle cell anemia.
• People recovering from acute blood loss (e.g., after surgery, trauma, or gastrointestinal bleeding).
• Individuals undergoing bone marrow suppression treatments (e.g., chemotherapy) to monitor the recovery of blood cell production.

The reticulocyte count is typically expressed as a percentage of the total red blood cell count or as the absolute reticulocyte count (the actual number of reticulocytes per microliter of blood). The reticulocyte production index (RPI) is a more specific measure that adjusts for the level of anemia. A high reticulocyte count usually indicates active production of red blood cells due to anemia or blood loss, while a low count might suggest inadequate bone marrow response.